530119 — Natraj Proteins Cashflow Statement
0.000.00%
- IN₹156.59m
- IN₹377.64m
- IN₹1.18bn
- 60
- 92
- 46
- 76
Annual cashflow statement for Natraj Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9.78 | 130 | 10.1 | -125 | -11.8 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 19 | 17.2 | 15.6 | 26.5 | 23.1 |
Other Non-Cash Items | |||||
Changes in Working Capital | 50 | -91.7 | -2 | 37.6 | 202 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 85.2 | 59 | 28 | -56 | 217 |
Capital Expenditures | -0.01 | -18.6 | -21.4 | -0.903 | -7.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1.29 | -15.4 | -6.85 | 5.74 | -17.4 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.3 | -33.9 | -28.3 | 4.83 | -24.9 |
Financing Cash Flow Items | -18.1 | -10.7 | -17.6 | -29.5 | -24.3 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -105 | 20.7 | -24 | 34.4 | -198 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -21 | 45.8 | -24.3 | -16.8 | -6.53 |